...
首页> 外文期刊>The Lancet >Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data.
【24h】

Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data.

机译:慢性阻塞性肺疾病患者双侧和单肺移植后的生存:登记数据的回顾性分析。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Both single and bilateral lung transplantation are recognised options for patients who have end-stage chronic obstructive pulmonary disease (COPD); however, which procedure leads to longer survival remains unclear. We aimed to compare survival after each procedure by analysing data from the registry of the International Society for Heart and Lung Transplantation. METHODS: We analysed data for 9883 patients with COPD, 3525 (35.7%) of whom underwent bilateral lung transplantation, and 6358 (64.3%) single lung transplantation, between 1987 and 2006. We accounted for possible selection bias with analysis of covariance, propensity-score risk adjustment, and propensity-based matching. FINDINGS: Median survival after either type of lung transplantation for patients with COPD was 5.0 years (95% CI 4.8-5.2). Survival for patients who had lung transplantation before 1998 was 4.5 years (4.3-4.8), compared with 5.3 years (5.0-5.5) for those who had it after 1998 (p<0.0001). The proportion of patients who had bilateral lung transplantation increased from 101/467 (21.6%) in 1993 to 345/614 (56.2%) in 2006. Median survival time after bilateral lung transplantation was longer than that after single lung transplantation: 6.41 years (6.02-6.88) versus 4.59 years (4.41-4.76) (p<0.0001). Pretransplant characteristics of patients who had single and bilateral lung transplantation differed, but whichever method was used to adjust for baseline differences, bilateral lung transplantation was associated with longer survival than was single lung transplantation; the hazard ratio ranged from 0.83 (0.78-0.92) for analysis of covariance to 0.89 (0.80-0.97) for propensity-based matching. However, bilateral lung transplantation had little benefit compared with single lung transplantation for patients who were 60 years and older (HR 0.95; 0.81-1.13). INTERPRETATION: Bilateral lung transplantation leads to longer survival than single lung transplantation in patients with COPD, especially those who are younger than 60 years.
机译:背景:对于患有终末期慢性阻塞性肺疾病(COPD)的患者,单侧和双侧肺移植都是公认的选择。但是,尚不清楚哪种方法可以延长生存期。我们旨在通过分析国际心脏和肺移植协会的注册数据来比较每种手术后的存活率。方法:我们分析了1987年至2006年间9883例COPD患者的数据,其中3525例(35.7%)进行了双侧肺移植,6358例(64.3%)进行了单肺移植。我们通过协方差,倾向分析来解释可能的选择偏倚得分风险调整,以及基于倾向的匹配。研究结果表明,COPD患者两种肺移植后的中位生存期均为5。0年(95%CI 4.8-5.2)。 1998年之前接受肺移植的患者的生存期为4.5年(4.3-4.8),而1998年以后接受肺移植的患者的生存期为5.3年(5.0-5.5)(p <0.0001)。进行双侧肺移植的患者比例从1993年的101/467(21.6%)增加到2006年的345/614(56.2%)。双侧肺移植后的中位生存时间比单肺移植后更长:6.41年( 6.02-6.88)对4.59年(4.41-4.76)(p <0.0001)。单肺和双肺移植患者的移植前特征不同,但是无论采用哪种方法来调整基线差异,双肺移植的生存期均比单肺移植长。风险比的范围从协方差分析的0.83(0.78-0.92)到基于倾向的匹配的0.89(0.80-0.97)。但是,对于60岁及以上的患者,双肺移植与单肺移植相比获益不大(HR 0.95; 0.81-1.13)。解释:对于COPD患者,尤其是60岁以下的患者,双肺移植比单肺移植的生存期更长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号